Editorial · 12 Dec 2025
EditorialPublished 25 Jan 2021
Type 1 & Type 2 Diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pitamapulae Horai Type 1 diabetes has not previously been considered, since it is generally viewed exclusively as an autoimmune disease. However, the pathophysiology of either disease is centered on β-cells, and type 1 and type 2 diabetes share many concerns, especially the goal of preserving or restoring a normal functional β-cell mass.Evidence has accumulated that immune tolerance reflects a permanent cross talk between the different cells involved in immune survey functions and peripheral tissues, as in the case of β-cells in type 1 diabetes. As in most common autoimmune diseases, the problem of the antigenic specificity of the autoimmune reaction that drives the β-cell damage has been one with most unpredictable issues over the past 20 years. Whether the activation of autoimmunity proceeds from intrinsic immune dysregulation or requires the presence of β-cells is now no longer a question. Against all predictions, the search for the “diabetes autoantigen” has resulted in a long list of candidates with rather loose identification criteria. All presently high-ranking β-cell autoantigens are defined as proteins expressed by β-cells, not as β-cell–specific antigens. Indeed, evidence has accumulated to indicate that B- and T-cells recognize many autoantigens, rather than a single autoantigen, during diabetes development and that most autoantigens are not β-cell specific. This makes type 1 diabetes a β-cell disease rather than an antigen-specific immune disease. As for type 2 diabetes, there is overwhelming evidence that it cannot be considered exclusively from the angle of the β-cell. β-Cells are at the center of multiple physiological loops that send signals and receive information to control energy disposal and storage. A key loop is the one between β-cells and adipocytes, establishing a direct link between metabolic and immune pathways. Many hormones, cytokines, transcription factors, and bioactive lipids are common to metabolic and immune pathways. Macrophages and adipocytes are overlapping cells that establish a functional link between energy storage functions and defense against pathogens. Not unexpectedly, obesity is associated with a state of chronic inflammation that has direct implications for the pathophysiology of type 2 diabetes. The close evolutionary links between immune and metabolic pathways raise the possibility that type 1 and type 2 diabetes may not be as different as initially thought. Moreover, uncommon forms of diabetes, namely latent autoimmune diabetes in adults (LADA), have been considered as possible overlaps between type 1 and type 2 diabetes. The lack, however, of clear biological criteria for the diagnosis of type 2 diabetes leaves open the issue of overlapping forms of diabetes. In addition to inflammation, which constitutes a possible link between type 1 and type 2 diabetes, both diseases are highly polygenic. Among the several problems that await solutions in type 1 and type 2 diabetes are the initial triggers that lead to failure of immune tolerance in type 1 diabetes and to failure of insulin secretion in type 2 diabetes, the relative contribution of environmental factors and of genetic variants to both diseases on a highly polygenic background, and others. Awards Nomination 20+ Million Readerbase
Keywords
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 11 Aug 2025
Emerging trends in artificial intelligenceâ??assisted insulin therapy for type 1 diabetes management
Article · 22 Jan 2025
Lipodystrophy with an uncommon clinical presentation in a patient with type 2 diabetes on insulin therapy
Article · 2025
Metformin Therapy and Its Role in Reducing Insulin Resistance in Type 2 Diabetes
Perspective · 2025
Cellular Insulin Insensitivity and Its Role in Type 2 Diabetes Development
More from this journal
The newest in Diabetes Management.
Article · 28 Oct 2025
Glucose control in older adults with diabetes following intra-articular and epidural triamcinolone acetonide injections
Article · 22 Jan 2025
Lipodystrophy with an uncommon clinical presentation in a patient with type 2 diabetes on insulin therapy
Article · 22 Jan 2025
Lipodystrophy with an uncommon clinical presentation in a patient with type 2 diabetes on insulin therapy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDiabetes Management
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Pitamapulae Horai”
